Affimed N.V. (NASDAQ:AFMD) Q1 2023 Earnings Conference Call May 23, 2023 8:30 AM ET

Company Participants

Alex Fudukidis - Director of Investor Relations

Adi Hoess - Chief Executive Officer

Andreas Harstrick - Chief Medical Officer

Angus Smith - Chief Financial Officer

Wolfgang Fischer - Chief Operating Officer

Arndt Schottelius - Chief Scientific Officer

Conference Call Participants

Maurice Raycroft - Jefferies

Li Watsek - Cantor Fitzgerald

Srikripa Devarakonda - Truist Securities

Bradley Canino - Stifel

Yale Jen - Laidlaw

Yanan Zhu - Wells Fargo Securities

Operator

Good day, everyone and welcome to Affimed's First Quarter 2023 Earnings and Corporate Update Call. At this time, all participants are in a listen-only mode. After the presentation there will be a question-and-answer session. [Operator Instructions] As a reminder, today's conference is being recorded.

I would now like to introduce your host for today's call, Alex Fudukidis, Head of Investor Relations at Affimed. Please go ahead.

Alex Fudukidis

Thank you, Liz and thank you all for joining us today for our first quarter 2023 update call. Before we begin, I'd like to remind everyone that we issued two relevant press releases earlier today which can be found on the Investor Relations section of our website. On the call today, we have the members of our management team, including Adi Hoess, our Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; Arndt Schottelius, our Chief Scientific Officer; Wolfgang Fischer, our Chief Operating Officer; Denise Mueller, our Chief Business Officer; and Angus Smith, our Chief Financial Officer. The team will be available for Q&A after the prepared remarks.

Before we start, I'd like to remind you that today's presentation contains projections and forward-looking statements regarding future events. These statements represent our beliefs and assumptions only as of the date of this call. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. These forward-looking statements are subject to risks and uncertainties and actual results may differ materially from those expressed or implied in these statements due to various factors, including but not limited to, those identified under the section entitled Risk Factors in our filings with the SEC and those identified under the section entitled Forward-Looking Statements in the press release that we issued today and filed with the SEC.